EP3813870
CCR5 INHIBITOR FOR USE IN TREATING CANCER
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
24.5.2019EP published:
15.11.2023EP application number:
19746141.1
EPO information:
European Patent Register
Max expiry date:
23.5.2039
Title in English:
CCR5 INHIBITOR FOR USE IN TREATING CANCERLanguage of the patent:
English
Timeline
Today
24.5.2019EP application
15.11.2023EP Publication
Owner
Name:
Orion Biotechnology Switzerland SàrlAddress:
Avenue de Sécheron 15, 1202 Geneva, CH
Inventor
Name:
HARTLEY, OliverAddress:
1256 Troinex, CH
Name:
OFFORD, Robin EwartAddress:
1233 Bernex, CH
Priority
Number:
201862677114 PDate:
28.5.2018Country:
US
Number:
201962792600 PDate:
15.1.2019Country:
US
Classification
Categories:
A61K 38/18, A61P 35/00